Inhaled vaccine for COVID-19 protects against variants of concern

In a groundbreaking development toward curbing the transmission of SARS-CoV-2, scientists have developed an innovative inhaled vaccine for COVID-19 that offers robust disease protection. Pioneered by a team at McMaster University, the innovative inhaled COVID-19 vaccine has been demonstrated to provide broad, long-lasting protection against the original strain of coronavirus and variants of concern (VOC). A study has signified that the revolutionary inhaled form of COVID-19 vaccine has substantial immune mechanisms and benefits due to being delivered directly into the respiratory tract compared to the standard method injection. The team’s research is published in the journal Cell